Manufactured Doubt: The Epistemology of Denial

The Tobacco Playbook

In 1969, a tobacco industry executive wrote a memo with one of the most revealing sentences in corporate history: 'Doubt is our product.' The tobacco industry spent decades funding scientists to publish research questioning the link between smoking and cancer — not to prove smoking was safe, but to create enough doubt to delay regulation.

The strategy is epistemological at its core. It exploits legitimate scientific norms — that knowledge is provisional, that dissent is healthy, that more research is always possible — and weaponizes them. By funding a small number of credentialed scientists to publish contrarian research, industries create the appearance of genuine scientific debate where the actual evidence is overwhelmingly one-sided.

The Playbook in Action Today

The same strategy has been deployed by fossil fuel companies against climate science, by chemical companies against pesticide regulation, by sugar companies against dietary guidelines, and by pharmaceutical companies against generic competition. The tactics are remarkably consistent:

1. Fund research that produces ambiguous results. 2. Amplify the ambiguity through think tanks and media. 3. Demand 'more research' before acting, knowing that research takes years. 4. Attack the integrity of scientists who produce inconvenient findings. 5. Frame regulation as based on 'uncertain science' rather than the overwhelming weight of evidence.

ExxonMobil's own internal research confirmed climate change in the 1970s — the same decade the company began funding external groups to cast doubt on climate science. This gap between private knowledge and public messaging is the hallmark of manufactured doubt.